Pages that link to "Item:Q3058549"
Jump to navigation
Jump to search
The following pages link to (Q3058549):
Displayed 17 items.
- Development of infrastructure of Latvian Institute of Organic Synthesis in the field of smart specialisation – biomedicine, medical technologies, biopharmaceuticals and biotechnologies (Q3056302) (← links)
- Development of malaria blood stage protease inchbiters (Q3056331) (← links)
- Synthesis and development of new Sigma-1 receptor positive alosthering modulators for Alzheimer’s therapy. (Q3056336) (← links)
- Low-molecular structure analogues of diazonamide as anticancer agents (Q3056364) (← links)
- Monocrystalline X-ray diffraction analysis of organic compounds included in the crystalline sponge (Q3056376) (← links)
- Development of Antimetastatic Nominees (Q3056377) (← links)
- Chemically modified spider silk (Q3056414) (← links)
- Next generation of induced emissions of luminogens as artificial light sources (Q3056415) (← links)
- Development of selective malaria treonyl-tRNA inhibitors (Q3056430) (← links)
- Development of new effective PARP inhibitors (Q3056438) (← links)
- Chain acylcarnitines in cardiovascular disease: New drug targets and diagnostic options (Q3056494) (← links)
- Support for international cooperation projects of the Latvian Institute of Organic Synthesis in research and innovation (Q3056535) (← links)
- Low fluorinated cycles for the design of medicinal products: Development of new fluoromethylene transfer reagents (Q3056538) (← links)
- Operation of amino acids using C(sp3)-H ligament activation approach (Q3056540) (← links)
- Synthesis and use of pyral/frustrated/Luis acid pairs in asymmetric catalysis (Q3056545) (← links)
- Development of biotechnology direction at the Latvian Institute of Organic Synthesis to achieve excellence in the field of drug detection (BioDrug) (Q3056546) (← links)
- Insulation of the warehouse building of the Latvian Institute of Organic Synthesis (Q3057011) (← links)